Epigenetics in blood–brain barrier disruption

27Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The vessels of the central nervous system (CNS) have unique barrier properties. The endothelial cells (ECs) which comprise the CNS vessels contribute to the barrier via strong tight junctions, specific transporters, and limited endocytosis which combine to protect the brain from toxins and maintains brain homeostasis. Blood–brain barrier (BBB) leakage is a serious secondary injury in various CNS disorders like stroke, brain tumors, and neurodegenerative disorders. Currently, there are no drugs or therapeutics available to treat specifically BBB damage after a brain injury. Growing knowledge in the field of epigenetics can enhance the understanding of gene level of the BBB and has great potential for the development of novel therapeutic strategies or targets to repair a disrupted BBB. In this brief review, we summarize the epigenetic mechanisms or regulators that have a protective or disruptive role for components of BBB, along with the promising approaches to regain the integrity of BBB.

Cite

CITATION STYLE

APA

Ihezie, S. A., Mathew, I. E., McBride, D. W., Dienel, A., Blackburn, S. L., & Thankamani Pandit, P. K. (2021, December 1). Epigenetics in blood–brain barrier disruption. Fluids and Barriers of the CNS. BioMed Central Ltd. https://doi.org/10.1186/s12987-021-00250-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free